GB0524589D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB0524589D0
GB0524589D0 GB0524589A GB0524589A GB0524589D0 GB 0524589 D0 GB0524589 D0 GB 0524589D0 GB 0524589 A GB0524589 A GB 0524589A GB 0524589 A GB0524589 A GB 0524589A GB 0524589 D0 GB0524589 D0 GB 0524589D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0524589A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0524589A priority Critical patent/GB0524589D0/en
Publication of GB0524589D0 publication Critical patent/GB0524589D0/en
Priority to EP10174132A priority patent/EP2305674A1/en
Priority to PCT/GB2006/002471 priority patent/WO2007007041A1/en
Priority to EP10174130A priority patent/EP2301929A1/en
Priority to US11/995,077 priority patent/US7642259B2/en
Priority to NZ575514A priority patent/NZ575514A/en
Priority to BRPI0613570A priority patent/BRPI0613570B8/en
Priority to JP2008520936A priority patent/JP4651714B2/en
Priority to AU2006268406A priority patent/AU2006268406C1/en
Priority to BRPI0622262-5A priority patent/BRPI0622262A2/en
Priority to KR1020117015352A priority patent/KR20110084339A/en
Priority to KR1020087002533A priority patent/KR101346902B1/en
Priority to CN200810169877.8A priority patent/CN101445505B/en
Priority to EP10174128A priority patent/EP2301935A1/en
Priority to ES06755703T priority patent/ES2397648T3/en
Priority to NZ564608A priority patent/NZ564608A/en
Priority to CA2614746A priority patent/CA2614746C/en
Priority to EP06755703A priority patent/EP1902052B1/en
Priority to MX2008000172A priority patent/MX2008000172A/en
Priority to RU2008101927/04A priority patent/RU2415141C2/en
Priority to BRPI0622261-7A priority patent/BRPI0622261A2/en
Priority to NZ575512A priority patent/NZ575512A/en
Priority to NZ575513A priority patent/NZ575513A/en
Priority to MYPI20063239A priority patent/MY147749A/en
Priority to ARP060102937A priority patent/AR055074A1/en
Priority to TW095124869A priority patent/TW200730174A/en
Priority to UY29656A priority patent/UY29656A1/en
Priority to SA06270215A priority patent/SA06270215B1/en
Priority to IL188059A priority patent/IL188059A0/en
Priority to NO20076658A priority patent/NO20076658L/en
Priority to EC2008008164A priority patent/ECSP088164A/en
Priority to HK08106758.1A priority patent/HK1116769A1/en
Priority to US12/202,800 priority patent/US7642263B2/en
Priority to US12/203,324 priority patent/US7842694B2/en
Priority to US12/256,254 priority patent/US7977328B2/en
Priority to JP2009157655A priority patent/JP4651729B2/en
Priority to JP2009157686A priority patent/JP2009263390A/en
Priority to JP2009157639A priority patent/JP2009215320A/en
Priority to AU2010235903A priority patent/AU2010235903B2/en
Priority to RU2010149302/04A priority patent/RU2010149302A/en
Priority to IL215102A priority patent/IL215102A0/en
Ceased legal-status Critical Current

Links

GB0524589A 2005-07-09 2005-12-02 Chemical compounds Ceased GB0524589D0 (en)

Priority Applications (41)

Application Number Priority Date Filing Date Title
GB0524589A GB0524589D0 (en) 2005-12-02 2005-12-02 Chemical compounds
BRPI0613570A BRPI0613570B8 (en) 2005-07-09 2006-07-03 compound, pharmaceutical composition and use of a compound or a pharmaceutically acceptable salt thereof
BRPI0622261-7A BRPI0622261A2 (en) 2005-07-09 2006-07-03 compound, pharmaceutical composition, use of a compound or a pharmaceutically acceptable salt thereof, and process for the preparation of a compound
NZ575513A NZ575513A (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
EP10174130A EP2301929A1 (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
NZ575512A NZ575512A (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
NZ575514A NZ575514A (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
AU2006268406A AU2006268406C1 (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
JP2008520936A JP4651714B2 (en) 2005-07-09 2006-07-03 Heteroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
PCT/GB2006/002471 WO2007007041A1 (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
BRPI0622262-5A BRPI0622262A2 (en) 2005-07-09 2006-07-03 compound, pharmaceutical composition, use of a compound or a pharmaceutically acceptable salt thereof, and process for the preparation of a compound
KR1020117015352A KR20110084339A (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
KR1020087002533A KR101346902B1 (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
CN200810169877.8A CN101445505B (en) 2005-07-09 2006-07-03 The heteroaryl benzamide derivatives of GLK activator is used as in treatment diabetes
EP10174128A EP2301935A1 (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ES06755703T ES2397648T3 (en) 2005-07-09 2006-07-03 Heteroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
NZ564608A NZ564608A (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
CA2614746A CA2614746C (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
EP06755703A EP1902052B1 (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
MX2008000172A MX2008000172A (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes.
RU2008101927/04A RU2415141C2 (en) 2005-07-09 2006-07-03 Heteroarylbenzamide derivatives applied as glk activators in diabetes treatment
EP10174132A EP2305674A1 (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US11/995,077 US7642259B2 (en) 2005-07-09 2006-07-03 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
MYPI20063239A MY147749A (en) 2005-07-09 2006-07-06 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
UY29656A UY29656A1 (en) 2005-07-09 2006-07-07 AMINO BENZOIL HETEROCICLILOS COMPOUND GROUPS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
ARP060102937A AR055074A1 (en) 2005-07-09 2006-07-07 DERIVATIVES OF HETEROARIL BENZAMIDAS AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS.
TW095124869A TW200730174A (en) 2005-07-09 2006-07-07 Chemical compounds
SA06270215A SA06270215B1 (en) 2005-07-09 2006-07-09 Heteroaryl Benzamide Derivatives for Use As GLK Activators in the Treatment of Diabetes
IL188059A IL188059A0 (en) 2005-07-09 2007-12-11 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
NO20076658A NO20076658L (en) 2005-07-09 2007-12-28 Heteroberl benzamide derivatives for use as GLK activators in the treatment of diabetes
EC2008008164A ECSP088164A (en) 2005-07-09 2008-02-08 DERIVATIVES OF HETEROARIL BENZAMIDA FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES
HK08106758.1A HK1116769A1 (en) 2005-07-09 2008-06-18 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
US12/202,800 US7642263B2 (en) 2005-07-09 2008-09-02 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US12/203,324 US7842694B2 (en) 2005-07-09 2008-09-03 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US12/256,254 US7977328B2 (en) 2005-07-09 2008-10-22 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
JP2009157639A JP2009215320A (en) 2005-07-09 2009-07-02 Heteroarylbenzamide derivative used for glk-activator in diabetic treatment
JP2009157655A JP4651729B2 (en) 2005-07-09 2009-07-02 Heteroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
JP2009157686A JP2009263390A (en) 2005-07-09 2009-07-02 Heteroaryl benzamide derivative for use as glk activator in treatment of diabetes
AU2010235903A AU2010235903B2 (en) 2005-07-09 2010-10-19 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
RU2010149302/04A RU2010149302A (en) 2005-07-09 2010-12-03 Heteroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
IL215102A IL215102A0 (en) 2005-07-09 2011-09-12 A heteroaryl benzamide derivative and a pharmaceutical composition containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0524589A GB0524589D0 (en) 2005-12-02 2005-12-02 Chemical compounds

Publications (1)

Publication Number Publication Date
GB0524589D0 true GB0524589D0 (en) 2006-01-11

Family

ID=35685934

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0524589A Ceased GB0524589D0 (en) 2005-07-09 2005-12-02 Chemical compounds

Country Status (1)

Country Link
GB (1) GB0524589D0 (en)

Similar Documents

Publication Publication Date Title
GB0504753D0 (en) Chemical compounds
GB0503056D0 (en) Chemical compounds
GB0511266D0 (en) Chemical compounds
GB0514018D0 (en) Chemical compounds
EP1951217A4 (en) Chemical compounds
EP1951250A4 (en) Chemical compounds
EP1919872A4 (en) Chemical compounds
GB0503053D0 (en) Chemical compounds
EP1940394A4 (en) Chemical compounds
EP1959737A4 (en) Chemical compounds
EP1948187A4 (en) Chemical compounds
EP1896014A4 (en) Chemical compounds
GB0503054D0 (en) Chemical compounds
GB0510852D0 (en) Chemical compounds
GB0504474D0 (en) Chemical compounds
GB0504475D0 (en) Chemical compounds
GB0507200D0 (en) Chemical compounds
GB0506886D0 (en) Chemical compounds
GB0514017D0 (en) Chemical compounds
GB0500301D0 (en) Chemical compounds
GB0514174D0 (en) Chemical compounds
GB0511851D0 (en) Chemical compounds
GB0514173D0 (en) Chemical compounds
GB0507347D0 (en) Chemical compounds
GB0506883D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)